Ling CC - Search Results

1

Perspectives of multidimensional conformal radiation treatment.

Ling CC, Burman C, Chui CS, Jackson A, Kutcher GJ, Leibel S, LoSasso T, Mageras G, Mohan R, Yorke E, et al. Ling CC, et al. Radiother Oncol. 1993 Nov;29(2):129-39. doi: 10.1016/0167-8140(93)90238-4. Radiother Oncol. 1993. PMID: 8310138

2

Intensity-modulated radiotherapy.

Leibel SA, Fuks Z, Zelefsky MJ, Wolden SL, Rosenzweig KE, Alektiar KM, Hunt MA, Yorke ED, Hong LX, Amols HI, Burman CM, Jackson A, Mageras GS, LoSasso T, Happersett L, Spirou SV, Chui CS, Ling CC. Leibel SA, et al. Among authors: ling cc. Cancer J. 2002 Mar-Apr;8(2):164-76. doi: 10.1097/00130404-200203000-00010. Cancer J. 2002. PMID: 12004802

3

Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer.

Levegrün S, Jackson A, Zelefsky MJ, Venkatraman ES, Skwarchuk MW, Schlegel W, Fuks Z, Leibel SA, Ling CC. Levegrün S, et al. Among authors: ling cc. Radiother Oncol. 2002 Apr;63(1):11-26. doi: 10.1016/s0167-8140(02)00062-2. Radiother Oncol. 2002. PMID: 12065099

4

Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy.

Mechalakos JG, Mageras GS, Zelefsky MJ, Lyass O, van Herk M, Kooy HM, Leibel SA, Ling CC. Mechalakos JG, et al. Among authors: ling cc. Radiother Oncol. 2002 Mar;62(3):261-5. doi: 10.1016/s0167-8140(01)00466-2. Radiother Oncol. 2002. PMID: 12175556

5

A study of the effects of internal organ motion on dose escalation in conformal prostate treatments.

Happersett L, Mageras GS, Zelefsky MJ, Burman CM, Leibel SA, Chui C, Fuks Z, Bull S, Ling CC, Kutcher GJ. Happersett L, et al. Among authors: ling cc. Radiother Oncol. 2003 Mar;66(3):263-70. doi: 10.1016/s0167-8140(03)00039-2. Radiother Oncol. 2003. PMID: 12742265

6

Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer.

Leibel SA, Fuks Z, Zelefsky MJ, Hunt M, Burman CM, Mageras GS, Chui CS, Jackson A, Amols HI, Ling CC. Leibel SA, et al. Among authors: ling cc. Semin Oncol. 2003 Oct;30(5):596-615. doi: 10.1016/s0093-7754(03)00354-3. Semin Oncol. 2003. PMID: 14571409 Review.

7

Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme.

Chan MF, Schupak K, Burman C, Chui CS, Ling CC. Chan MF, et al. Among authors: ling cc. Med Dosim. 2003 Winter;28(4):261-5. doi: 10.1016/j.meddos.2003.08.004. Med Dosim. 2003. PMID: 14684191

8

From IMRT to IGRT: frontierland or neverland?

Ling CC, Yorke E, Fuks Z. Ling CC, et al. Radiother Oncol. 2006 Feb;78(2):119-22. doi: 10.1016/j.radonc.2005.12.005. Epub 2006 Jan 18. Radiother Oncol. 2006. PMID: 16413622

9

High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model.

Ling CC, Sahoo N, Leibel S, Anderson LL. Ling CC, et al. Radiother Oncol. 1992 Oct;25(2):103-10. doi: 10.1016/0167-8140(92)90016-n. Radiother Oncol. 1992. PMID: 1438929

10

Clinically relevant optimization of 3-D conformal treatments.

Mohan R, Mageras GS, Baldwin B, Brewster LJ, Kutcher GJ, Leibel S, Burman CM, Ling CC, Fuks Z. Mohan R, et al. Among authors: ling cc. Med Phys. 1992 Jul-Aug;19(4):933-44. doi: 10.1118/1.596781. Med Phys. 1992. PMID: 1518482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters